{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:57:11Z","timestamp":1789541831255,"version":"build-2803163510"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To discuss the use of vasopressors and inotropes in cardiogenic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The classic form or cardiogenic shock requires administration of inotropic and\/or vasopressor agents to try to improve the impaired tissue perfusion. Among vasopressors various alpha-adrenergic agents, vasopressin derivatives and angiotensin can be used. The first-line therapy remains norepinephrine as it is associated with minimal adverse effects and appears to be associated by the best outcome in network meta-analyses. On the contrary, epinephrine is associated with an increased incidence of refractory shock and observational studies suggest an increased risk of death. Vasopressin may be an excellent alternative in tachycardiac patients or in the presence of pulmonary hypertension. Concerning inotropic agents, dobutamine is the first-line agent but levosimendan is an excellent alternative or additional agent in cases not responding to dobutamine. The impact on outcome of inotropic agents remains controversial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Recent studies have refined the position of the various vasopressor and inotropic agents. Norepinephrine is recommended as first-line vasopressor agent by various guidelines. Among inotropic agents, selection between the agents should be individualized and based on the hemodynamic response.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000822","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T09:01:30Z","timestamp":1617354090000},"page":"426-432","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["The medical treatment of cardiogenic shock: cardiovascular drugs"],"prefix":"10.1097","volume":"27","author":[{"given":"Daniel","family":"De Backer","sequence":"first","affiliation":[{"name":"Department of Intensive Care, CHIREC Hospitals, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Arias Ortiz","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, National ECMO Center, Calderon Guardia Hospital, Universidad de Costa Rica, San Jos\u00e9, Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Levy","sequence":"additional","affiliation":[{"name":"CHRU Nancy, Service de R\u00e9animation M\u00e9dicale Brabois, P\u00f4le Cardiovasculaire et R\u00e9animation M\u00e9dicale, H\u00f4pital Brabois, Vandoeuvre les Nancy, France"},{"name":"INSERM U 1116, Groupe Choc, Equipe 2, Facult\u00e9 de M\u00e9decine, Vandoeuvre les Nancy, France"},{"name":"Universit\u00e9 de Lorraine, Facult\u00e9 de M\u00e9decine, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00134-014-3525-z","article-title":"Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine","volume":"40","author":"Cecconi","year":"2014","journal-title":"Intensive Care Med"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4615-9014-9_3","article-title":"Proposed reclassification of shock states with special reference to distributive defects","volume":"23","author":"Weil","year":"1971","journal-title":"Adv Exp Med Biol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N Engl J Med"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1378\/chest.124.5.1885","article-title":"Do all nonsurvivors of cardiogenic shock die with a low cardiac index?","volume":"124","author":"Lim","year":"2003","journal-title":"Chest"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2003.07.006","article-title":"Microvascular alterations in patients with acute severe heart failure and cardiogenic shock","volume":"147","author":"De Backer","year":"2004","journal-title":"Am Heart J"},{"key":"R7-20250729","first-page":"108","article-title":"Prognostic implications of microcirculatory perfusion versus macrocirculatory perfusion in cardiogenic shock: a CULPRIT-SHOCK substudy","volume":"9","author":"Wijntjens","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1093\/eurheartj\/ehq324","article-title":"Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock","volume":"31","author":"den Uil","year":"2010","journal-title":"Eur Heart J"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur Heart J"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"H725","DOI":"10.1152\/ajpheart.00621.2020","article-title":"Cardiac \u03b11A-adrenergic receptors: emerging protective roles in cardiovascular diseases","volume":"320","author":"Zhang","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/cvr\/cvr081","article-title":"Regulation of murine cardiac contractility by activation of ((1A)-adrenergic receptor-operated Ca(2+) entry","volume":"91","author":"Mohl","year":"2011","journal-title":"Cardiovasc Res"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJM195209112471102","article-title":"The clinical use of norepinephrine in the treatment of shock accompanying myocardial infarction and other conditions","volume":"247","author":"Kurland","year":"1952","journal-title":"N Engl J Med"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/01.CIR.67.3.620","article-title":"Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock","volume":"67","author":"Richard","year":"1983","journal-title":"Circulation"},{"key":"R14-20250729","first-page":"e82","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"e8402","DOI":"10.1097\/MD.0000000000008402","article-title":"Dopamine versus norepinephrine in the treatment of cardiogenic shock: a PRISMA-compliant meta-analysis","volume":"96","author":"Rui","year":"2017","journal-title":"Medicine"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1476-5381.1960.tb01261.x","article-title":"The effect of adrenaline and noradrenaline on the metabolism and performance of the isolated dog heart","volume":"15","author":"Fawaz","year":"1960","journal-title":"Br J Pharmacol Chemother"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/CCM.0b013e3181ffe0eb","article-title":"Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study","volume":"39","author":"Levy","year":"2011","journal-title":"Crit Care Med"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13054-016-1387-1","article-title":"Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality","volume":"20","author":"Tarvasmaki","year":"2016","journal-title":"Crit Care"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-018-5222-9","article-title":"Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients","volume":"44","author":"Leopold","year":"2018","journal-title":"Intensive Care Med"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4103\/0366-6999.205862","article-title":"Clinical characteristics and current interventions in shock patients in Chinese emergency departments: a multicenter prospective cohort study","volume":"130","author":"Guo","year":"2017","journal-title":"Chin Med J"},{"key":"R23-20250729","first-page":"959","article-title":"Efficacy of hypertensin 2 in a case of severe cardiogenic shock resistant to therapy with noradrenalin","volume":"58","author":"Burchardt","year":"1960","journal-title":"Hospital"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0002-9610(86)90017-6","article-title":"Pathophysiology of hepatic ischemia in cardiogenic shock","volume":"151","author":"Bulkley","year":"1986","journal-title":"Am J Surg"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13054-017-1896-6","article-title":"The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature","volume":"21","author":"Busse","year":"2017","journal-title":"Crit Care"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13613-018-0448-9","article-title":"Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the MIMIC-III database","volume":"8","author":"Vincent","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/SHK.0000000000000099","article-title":"Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: effects on hemodynamics and tissue oxygenation","volume":"41","author":"Perez","year":"2014","journal-title":"Shock"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/CH-16156","article-title":"Effect of increasing mean arterial blood pressure on microcirculation in patients with cardiogenic shock supported by extracorporeal membrane oxygenation","volume":"70","author":"Du","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13054-020-2816-8","article-title":"Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock","volume":"24","author":"Udesen","year":"2020","journal-title":"Crit Care"},{"key":"R31-20250729","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000001747","article-title":"Comparison of vasopressin versus norepinephrine in a pig model of refractory cardiogenic shock complicated by cardiac arrest and resuscitated with veno-arterial ECMO","author":"Klein","year":"2021","journal-title":"Shock"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13054-018-2225-4","article-title":"Angiotensin in ECMO patients with refractory shock","volume":"22","author":"Ostermann","year":"2018","journal-title":"Crit Care"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-8703(67)90079-8","article-title":"Effect of isoproterenol and norepinephrine on myocardial function in experimental cardiogenic shock","volume":"74","author":"Cronin","year":"1967","journal-title":"Am Heart J"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(74)91754-1","article-title":"Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine","volume":"ii","author":"Jewitt","year":"1974","journal-title":"Lancet"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1152\/ajplegacy.1965.209.5.913","article-title":"Mechanism of increase of myocardial oxygen uptake produced by catecholamines","volume":"209","author":"Klocke","year":"1965","journal-title":"Am J Physiol"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1536\/ihj.38.515","article-title":"The effects of dopamine, dobutamine and amrinone on mitochondrial function in cardiogenic shock","volume":"38","author":"Mukae","year":"1997","journal-title":"Jpn Heart J"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0002-9149(90)91316-X","article-title":"Hemodynamic and oxygen transport variables in cardiogenic shock secondary to acute myocardial infarction and response to treatment","volume":"65","author":"Creamer","year":"1990","journal-title":"Am J Cardiol"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13613-021-00806-8","article-title":"Current use of inotropes in circulatory shock","volume":"11","author":"Scheeren","year":"2021","journal-title":"Ann Intensive Care"},{"key":"R39-20250729","first-page":"Cd009669","article-title":"Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome","volume":"11","author":"Uhlig","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R40-20250729","first-page":"382","article-title":"Reversal of propranolol blockade of adrenergic receptors and related toxicity with drugs that increase cyclic AMP","volume":"221","author":"Whitehurst","year":"1999","journal-title":"Proc Soc Exp Biol Med"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0002-9149(88)90970-8","article-title":"Administration of enoximone in cardiogenic shock","volume":"62","author":"Vincent","year":"1988","journal-title":"Am J Cardiol"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"8862256","DOI":"10.1155\/2020\/8862256","article-title":"Network meta-analysis of the safety of drug therapy for cardiogenic shock","volume":"2020","author":"Liao","year":"2020","journal-title":"J Healthc Eng"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"A125","DOI":"10.1161\/circ.142.suppl_4.125","article-title":"Abstract 125: Capital Do-Re-Mi: a randomized trial of dobutamine compared to milrinone in cardiogenic shock","volume":"142","author":"Mathew","year":"2020","journal-title":"Circulation"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FJC.0000000000000859","article-title":"Levosimendan efficacy and safety: 20 Years of SIMDAX in clinical use","volume":"76","author":"Papp","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/CCM.0b013e3181809846","article-title":"Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction","volume":"36","author":"Fuhrmann","year":"2008","journal-title":"Crit Care Med"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00134-013-2945-5","article-title":"Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock","volume":"39","author":"Taccone","year":"2013","journal-title":"Intensive Care Med"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/17482940902807286","article-title":"Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance","volume":"11","author":"Tsagalou","year":"2009","journal-title":"Acute Card Care"},{"key":"R48-20250729","doi-asserted-by":"crossref","DOI":"10.1053\/j.jvca.2021.01.019","article-title":"The effectiveness of levosimendan on veno-arterial extracorporeal membrane oxygenation management and outcome: a systematic review and meta-analysis","author":"Kaddoura","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R49-20250729","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13613-019-0503-1","article-title":"Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit","volume":"9","author":"Vally","year":"2019","journal-title":"Ann Intensive Care"},{"key":"R50-20250729","doi-asserted-by":"crossref","DOI":"10.1111\/aor.13899","article-title":"Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: impact on the success of weaning and survival","author":"Alonso-Fernandez-Gatta","year":"2021","journal-title":"Artif Organs"},{"key":"R51-20250729","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13054-020-03122-y","article-title":"Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis","volume":"24","author":"Guilherme","year":"2020","journal-title":"Crit Care"},{"key":"R52-20250729","first-page":"29","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:15:03Z","timestamp":1753820103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000822","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]}}}